Find A Portfolio/Ticker
Comparison Box
MyPlanIQ
401k Investor
Medline Industries Inc. Employees Profit Sharing Retirement Plan
Medline Industries Inc. Employees Profit Sharing Retirement Plan Strategic Asset Allocation - Optimal Moderate
Medline Industries Inc. Employees Profit Sharing Retirement Plan Strategic Asset Allocation - Optimal Moderate
live (public) 0.01% January 08
Delayed
Holdings (As of 10/31/2024)
sign up and login first and then customize a new portfolio for the latest current holdings
| Asset | Fund in this portfolio | Price change* | Original Fund Description | Percentage |
|---|---|---|---|---|
| General Bond | VBMFX (VANGUARD TOTAL BOND MARKET INDEX FUND INVESTOR SHARES) | 0.10% | total bond market index fund | 38.58% |
| US Equity | PRGFX (T. ROWE PRICE GROWTH STOCK FUND INC. T. ROWE PRICE GROWTH STOCK FUND INC.) | 2.70% | trp growth stock fund | 15.63% |
| US Equity | VFINX (VANGUARD 500 INDEX FUND INVESTOR SHARES) | 1.85% | 500 index fund investor shares | 16.25% |
| CASH | CASH (CASH) | 0.0% | prime money market fund | 0.12% |
| Emerging Market Equity | EMGAX (WELLS FARGO EMERGING MARKETS EQUITY FUND CLASS A) | 1.20% | Wells Fargo Advantage Emerg Mkts Eq A | 10.74% |
| International Equity | VWIGX (VANGUARD INTERNATIONAL GROWTH FUND INVESTOR SHARES) | 1.02% | international growth fund investor shares | 18.68% |
* Day change on 10/31/2024.
Previous
Beta
Performance (As of 01/08/2025)
Since 12/31/2000
| Name | YTD* Return |
1Yr AR** |
3Yr AR** |
5Yr AR** |
10Yr AR** |
15Yr AR** |
|---|---|---|---|---|---|---|
| Medline Industries Inc. Employees Profit Sharing Retirement Plan Strategic Asset Allocation - Optimal Moderate | 2.8% | 23.0% | 0.3% | 6.4% | 6.1% | 7.1% |
| VFINX (Vanguard (S&P 500) Index) | 8.4% | 25.7% | 21.5% | 13.2% | 15.2% | 14.2% |
| VBINX (Vanguard Balance (60% stocks/40% bonds) | 5.2% | 17.0% | 14.2% | 7.3% | 9.5% | 9.2% |
* YTD: Year to Date
** AR: Annualized Return
** portfolio AR is delayed
| Last 1 Week* | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | 20 Yr | Since 01/02/2001 |
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annualized Return(%) | -1.0 | 23.0 | 0.3 | 6.4 | 6.1 | 7.1 | 6.9 | 6.6 | 0.5 | 7.4 | 10.3 | -16.1 | 3.1 | 24.3 | 20.8 | -6.0 | 15.0 | 5.7 | 0.1 | 2.7 | 11.7 | 10.6 | -0.1 | 15.9 | 23.7 | -22.4 | 12.0 | 14.5 | 9.1 | 11.9 | 24.9 | -5.4 | -0.8 |
| Sharpe Ratio | NA | 0.26 | -0.32 | 0.19 | 0.4 | NA | NA | 0.48 | 0.04 | 0.09 | 0.68 | -1.2 | 0.3 | 1.33 | 2.77 | -0.73 | 2.9 | 0.66 | 0.01 | 0.4 | 1.65 | 1.38 | -0.01 | 1.32 | 1.43 | -1.08 | 0.87 | 1.3 | 1.06 | 1.33 | 3.03 | -0.62 | -0.32 |
| Draw Down(%) | NA | 6.0 | 22.5 | 25.4 | 25.4 | NA | NA | 35.6 | 0.8 | 6.0 | 9.2 | 22.9 | 8.0 | 19.7 | 3.7 | 13.2 | 2.5 | 6.4 | 9.2 | 5.2 | 6.4 | 6.4 | 13.0 | 8.2 | 17.0 | 33.1 | 7.0 | 10.3 | 4.6 | 8.9 | 6.8 | 16.6 | 15.6 |
| Standard Deviation(%) | NA | 9.4 | 11.3 | 12.8 | 10.6 | NA | NA | 11.0 | 9.7 | 9.5 | 8.9 | 14.6 | 10.3 | 18.1 | 7.0 | 10.0 | 5.0 | 8.3 | 8.5 | 6.7 | 7.1 | 7.7 | 13.6 | 12.0 | 16.6 | 21.6 | 10.4 | 8.6 | 6.5 | 8.2 | 8.0 | 10.5 | 9.6 |
| Treynor Ratio | NA | 0.04 | -0.06 | 0.05 | 0.08 | NA | NA | 0.1 | 0.01 | 0.01 | 0.1 | -0.32 | 0.05 | 0.49 | 0.37 | -0.13 | 0.26 | 0.09 | 0.0 | 0.05 | 0.2 | 0.19 | 0.0 | 0.25 | 0.4 | -0.46 | 0.15 | 0.15 | 0.13 | 0.19 | 0.64 | -0.19 | -0.08 |
| Alpha | NA | -0.03 | -0.02 | -0.01 | 0.0 | NA | NA | 0.01 | 0.01 | -0.04 | -0.02 | -0.03 | -0.05 | 0.05 | 0.02 | -0.01 | 0.02 | 0.0 | 0.0 | -0.01 | -0.02 | 0.01 | 0.0 | 0.03 | 0.03 | -0.01 | 0.03 | 0.01 | 0.02 | 0.02 | 0.05 | 0.01 | 0.01 |
| Beta | NA | 0.66 | 0.57 | 0.54 | 0.54 | NA | NA | 0.52 | 0.66 | 0.67 | 0.59 | 0.54 | 0.61 | 0.49 | 0.52 | 0.54 | 0.54 | 0.59 | 0.51 | 0.54 | 0.58 | 0.57 | 0.56 | 0.63 | 0.58 | 0.5 | 0.61 | 0.74 | 0.53 | 0.57 | 0.38 | 0.34 | 0.39 |
| RSquared | NA | 0.79 | 0.79 | 0.8 | 0.81 | NA | NA | 0.82 | 0.92 | 0.79 | 0.76 | 0.81 | 0.59 | 0.9 | 0.85 | 0.86 | 0.54 | 0.85 | 0.86 | 0.85 | 0.83 | 0.9 | 0.92 | 0.91 | 0.92 | 0.91 | 0.88 | 0.74 | 0.71 | 0.6 | 0.65 | 0.71 | 0.74 |
| Sortino Ratio | NA | 0.35 | -0.45 | 0.26 | 0.54 | NA | NA | 0.66 | 0.06 | 0.12 | 1.0 | -1.65 | 0.41 | 1.74 | 4.15 | -0.96 | 4.1 | 0.91 | 0.01 | 0.56 | 2.36 | 2.11 | -0.01 | 1.92 | 2.09 | -1.42 | 1.2 | 1.92 | 1.58 | 1.83 | 4.68 | -0.87 | -0.44 |
| Yield(%) | N/A | 1.6 | 2.3 | 3.5 | 3.7 | 4.5 | 6.3 | 3.32 | N/A | 1.6 | 2.8 | 3.1 | 4.3 | 3.5 | 2.4 | 3.0 | 0.4 | 2.4 | 3.3 | 2.7 | 2.0 | 2.2 | 2.4 | 2.1 | 2.6 | 5.3 | 6.5 | 7.5 | 4.0 | 3.4 | 2.8 | 3.4 | 3.6 |
| Dividend Growth(%) | N/A | -40.5 | -18.8 | 96.0 | 47.3 | N/A | N/A | N/A | N/A | -40.5 | -22.7 | -25.8 | 51.1 | 74.4 | -22.5 | 726.2 | -81.4 | -28.5 | 24.6 | 47.7 | 2.9 | -9.4 | 31.8 | -0.7 | -61.2 | -8.8 | -1.6 | 110.1 | 29.5 | 49.0 | -19.5 | -6.4 | N/A |
*: NOT annualized;YTD: Year to Date
**Inception: starting from 12/31/2000
Portfolio Description
This model portfolio uses Strategic Asset Allocation - Optimal
strategy. Asset weights of available asset classes
in Medline Industries Inc. Employees Profit Sharing Retirement Plan are derived based on long term asset trends and their correlations.
For each major asset class, one or two funds are selected:
1. Risk allocation: the risk profile of this portfolio is 40.
The total allocation of the fixed income asset should be at least 40%.
2. Asset weights:
3. Fund selection: one or two top performing funds among 26 available funds in the plan are chosen for each asset.
They are usually equally weighted within the asset by default. Volatile funds or ETFs with small trading volume are ignored.
4. Rebalance frequency: the portfolio is reviewed by the strategy program monthly
and the above steps are repeated. Asset weights are rebalanced back to target allocation if it is necessary.
5.
Simulation: Performance data before this portfolio went public are obtained from historical simulation. They are hypothetical.
Register for FREE
No Credit Card Required
Or Start FREE 30-day trial now >>
Or Start FREE 30-day trial now >>